Latrobe Magnesium locks in A$8.5m to push toward first metal production

Latrobe Magnesium has secured A$8.5 million in equity funding to complete its Latrobe Valley demonstration plant and advance a proposed South Carolina magnesium project. The raising gives the company near-term funding certainty, but also brings further dilution and leaves the larger US development dependent on future capital.

  • A$5.1m institutional placement at A$0.015 a share
  • Fully underwritten A$3.4m one-for-15 entitlement offer
  • Funds Phase 1B completion and 2026 magnesium crown campaign
  • A$0.5m allocated to initial South Carolina plant studies
  • Existing shareholders face up to 14.23% dilution if they do not participate
An image related to Latrobe Magnesium Limited
Image © middle. Logo © respective owner.

A$8.5m raising funds the next technical test

Latrobe Magnesium Limited (ASX:LMG) has secured firm commitments for A$8.5 million, giving the magnesium developer cash to finish the most immediate test of its strategy: completing the pyrometallurgical section of its Latrobe Valley demonstration plant and running a campaign to produce magnesium crowns by the end of 2026.

The raising combines a A$5.1 million placement of about 339 million shares with a fully underwritten A$3.4 million non-renounceable entitlement offer. Both are priced at A$0.015 a share. That represents a 6.8% discount to LMG’s five-day volume-weighted average price, although the placement was struck at a 9.2% premium to the 15-day VWAP.

Demonstration plant takes priority

LMG plans to direct A$3.8 million to Phase 1B completion, including the furnace, retort assembly, briquette plant and automated loading equipment. A further A$1.7 million is earmarked for the magnesium crown commissioning campaign and site running costs, while A$1.3 million will fund long-lead items for the subsequent refinery stage.

The company says its hydrometallurgical circuit has already produced 20 tonnes of magnesium oxide at about 90% quality over a sustained two-week campaign. The pyrometallurgical plant is described as 70% complete. The next milestone is more demanding: demonstrating safe and reliable operation of the automated system in a four-week campaign intended to produce crowns containing more than 98% magnesium.

South Carolina option receives initial funding

Only A$500,000 of the raising is allocated to commercial plant studies, including the initial work on LMG’s proposed 50 kilotonne-per-year South Carolina facility. The company has identified a preferred site and is negotiating land and infrastructure arrangements, while a non-binding US$15 million letter of support remains conditional on LMG securing a further US$15 million for the feasibility study.

That project is therefore still an option rather than a funded construction decision. LMG’s indicative timetable targets feasibility study completion in early 2028, a final investment decision in March 2028 and first production in April 2030. The company also flags unresolved requirements including site acquisition, rezoning, permits, engineering work, financing and binding offtake agreements.

Dilution and balance-sheet pressure remain

The capital raising will increase shares on issue from about 3.415 billion to approximately 3.982 billion if fully completed, before any relevant option exercises. A shareholder who takes up their entitlement but does not receive additional shortfall shares will still be diluted by about 8.51% from the placement; a shareholder who does not participate in the entitlement offer could face aggregate dilution of up to 14.23%.

LMG also plans to pay Long State A$191,429 to settle the swap component of its earlier funding arrangement. Long State is selling its remaining LMG shares through a secondary-market trade and will retain no shareholding, while LMG says it does not intend to use the facility as an equity funding source going forward. The company’s proposed A$4.5 million FY27 research and development tax rebate is embedded in the funding plan, but the rebate remains an estimate rather than cash already received.

Commissioning now carries the story

The raising removes one immediate funding hurdle, but it does not convert LMG into a producer. The crucial evidence will be whether the crown campaign runs safely, on budget and at the expected quality, followed by funding for the refinery and a sustained ash-to-ingot operating campaign. The larger US ambition will require a much more substantial financing package after the current study work.

Bottom Line?

LMG has bought itself a clearer run at its first magnesium-metal campaign, but the investment case now turns on plant performance, the R&D rebate and whether the South Carolina option can attract project-level capital.

Questions in the middle?

  • Can the Phase 1B crown campaign demonstrate reliable operation within the A$1.0 million campaign budget?
  • When will the estimated FY27 R&D tax rebate be received, and how much will ultimately be approved?
  • Can LMG secure the remaining US$15 million study funding and convert its South Carolina project into a bankable development?